Effect of the Covid-19 pandemic on hospitalizations for non-Covid-19-pneumonia and exacerbations of chronic obstructive pulmonary diseases in Switzerland: comparison of national data between 2020/2021 and 2015-2019

RECOMMENDED

COPDFurther Publications

Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021

★ 2 Recommended by Dr Martin Frey, Faculty Member

Respir Res

Wang Z, Lin J, Liang L, Huang F, Yao X, Peng K, Gao Y, Zheng J

doi: 10.1186/s12931-024-03051-2

COMMENTED

COPD

Exacerbation history and risk of myocardial infarction and pulmonary embolism in chronic obstructive pulmonary disease

★ 3 Recommended and commented by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

Chest

Wallström O, Stridsman C, Lindberg A, Nyberg F, Vanfleteren LEGW

doi: 10.1016/j.chest.2024.07.150

COPD

A Comparison of GOLD and STAR Severity Stages in Individuals with Chronic Obstructive Pulmonary Disease Undergoing Pulmonary Rehabilitation

Chest

Ambrosino P, Vitacca M, Marcuccio G, Spanevello A, Ambrosino N, Maniscalco M

doi: 10.1016/j.chest.2024.10.013

Respiratory Tract Infection

Adiposity and mortality among intensive care patients with COVID-19 and non-COVID-19 respiratory conditions: a cross-context comparison study in the UK

BMC Med

Bell JA, Carslake D, Hughes A, Tilling K, Dodd JW, Doidge JC, Harrison DA, Rowan KM, Davey Smith G

doi: 10.1186/s12916-024-03598-3

Pulmonary Hypertension

Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

Lancet Respir Med

GBD 2021 Pulmonary Arterial Hypertension Collaborators

doi: 10.1016/S2213-2600(24)00295-9

COMMENTED

COPD

Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine Reduces Exacerbation Rate and Risk in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

★ 3 Recommended and commented by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

Chest

Sciurba FC, Christenson SA, Rheault T, Bengtsson T, Rickard K, Barjaktarevic IZ

doi: 10.1016/j.chest.2024.07.168

RECOMMENDED

COPD

Use of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitor is Associated with reduced Emergency Room Visits and Hospitalization in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Diabetes Mellitus

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Respir Med

Shanmugavel Geetha H, Teo YX, Ravichandran S, Perkitt NR, Gogtay M, Lal A, Abraham GM, Trivedi N

doi: 10.1016/j.rmed.2024.107819

RECOMMENDED

AsthmaCOPDInterstitial Lung Disease

Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland

★ 2 Recommended by Dr Martin Frey, Faculty Member

Thorax

Whittaker H, Kramer Fiala Machado A, Hatam S, Cook S, Scully S, Evans HTT, Bolton T, Kallis C, Busby J, Heaney LG, Sheikh A, Quint JK, CVD-COVID-UK/COVID-IMPACT Consortium

doi: 10.1136/thorax-2024-222699

AsthmaCOPD

Burden of Respiratory Syncytial Virus Disease in Adults with Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

Curr Allergy Asthma Rep

Penders Y, Brusselle G, Falsey AR, Rohde G, Betancur E, Guardado ME, Agudelo JLR, Saeedi P, Harrington L, Michaud JP

doi: 10.1007/s11882-025-01194-w

Related content

Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021

Exacerbation history and risk of myocardial infarction and pulmonary embolism in chronic obstructive pulmonary disease

A Comparison of GOLD and STAR Severity Stages in Individuals with Chronic Obstructive Pulmonary Disease Undergoing Pulmonary Rehabilitation

Adiposity and mortality among intensive care patients with COVID-19 and non-COVID-19 respiratory conditions: a cross-context comparison study in the UK

Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine Reduces Exacerbation Rate and Risk in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

Use of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitor is Associated with reduced Emergency Room Visits and Hospitalization in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Diabetes Mellitus

Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland

Burden of Respiratory Syncytial Virus Disease in Adults with Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review